Qiagen NV has a consensus price target of $42.13 based on the ratings of 21 analysis. The 3 most-recent analyst ratings were released by Wolfe Research, JP Morgan, and Stifel on June 27, 2024, June 18, 2024, and May 1, 2024, respectively. With an average price target of $49.67 between Wolfe Research, JP Morgan, and Stifel, there's an implied 21.05% upside for Qiagen NV from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
06/27/2024 | Buy Now | 21.86% | Wolfe Research | Doug Schenkel | → $50 | Upgrade | Peer Perform → Outperform | Get Alert |
06/18/2024 | Buy Now | 31.61% | JP Morgan | Casey Woodring | $52 → $54 | Maintains | Overweight | Get Alert |
05/01/2024 | Buy Now | 9.68% | Stifel | Daniel Arias | $55 → $45 | Maintains | Hold | Get Alert |
02/16/2024 | Buy Now | 24.3% | Morgan Stanley | Steve Beuchaw | $49.48 → $51 | Upgrade | Equal-Weight → Overweight | Get Alert |
02/08/2024 | Buy Now | 26.74% | JP Morgan | Casey Woodring | $50 → $52 | Maintains | Overweight | Get Alert |
02/08/2024 | Buy Now | 46.23% | Citigroup | Patrick Donnelly | $61.86 → $60 | Maintains | Buy | Get Alert |
12/20/2023 | Buy Now | 21.86% | JP Morgan | Casey Woodring | $46.35 → $51.5 | Maintains | Overweight | Get Alert |
12/19/2023 | Buy Now | 7.24% | Wells Fargo | Timothy Daley | → $45.32 | Initiates | → Equal-Weight | Get Alert |
12/13/2023 | Buy Now | — | Wolfe Research | Doug Schenkel | — | Initiates | → Peer Perform | Get Alert |
12/07/2023 | Buy Now | — | Goldman Sachs | Matthew Sykes | — | Upgrade | Neutral → Buy | Get Alert |
11/02/2023 | Buy Now | 2.36% | UBS | John Sourbeer | $49.44 → $43.26 | Maintains | Neutral | Get Alert |
10/17/2023 | Buy Now | 21.86% | JP Morgan | Casey Woodring | $56.65 → $51.5 | Maintains | Overweight | Get Alert |
09/26/2023 | Buy Now | 46.23% | Citigroup | Patrick Donnelly | $61.8 → $61.8 | Reiterates | Buy → Buy | Get Alert |
09/12/2023 | Buy Now | 21.86% | Baird | Catherine Schulte | → $51.5 | Initiates | → Outperform | Get Alert |
08/09/2023 | Buy Now | 16.99% | UBS | John Sourbeer | $51.5 → $49.44 | Maintains | Neutral | Get Alert |
02/09/2023 | Buy Now | 26.74% | UBS | John Sourbeer | $51.5 → $53.56 | Maintains | Neutral | Get Alert |
02/09/2023 | Buy Now | 46.23% | Citigroup | Patrick Donnelly | $56.65 → $61.8 | Maintains | Buy | Get Alert |
11/09/2022 | Buy Now | 34.05% | Citigroup | Patrick Donnelly | $63.86 → $56.65 | Maintains | Buy | Get Alert |
12/14/2021 | Buy Now | 46.23% | Wells Fargo | Dan Leonard | $59.74 → $61.8 | Maintains | Equal-Weight | Get Alert |
10/14/2021 | Buy Now | — | Redburn Partners | Simon Baker | — | Initiates | → Buy | Get Alert |
07/14/2021 | Buy Now | 20.72% | Kepler Cheuvreux | Maja Pataki | → $51.02 | Downgrade | Buy → Hold | Get Alert |
The latest price target for Qiagen (NYSE:QGEN) was reported by Wolfe Research on June 27, 2024. The analyst firm set a price target for $50.00 expecting QGEN to rise to within 12 months (a possible 21.86% upside). 15 analyst firms have reported ratings in the last year.
The latest analyst rating for Qiagen (NYSE:QGEN) was provided by Wolfe Research, and Qiagen upgraded their outperform rating.
The last upgrade for Qiagen NV happened on June 27, 2024 when Wolfe Research raised their price target to $50. Wolfe Research previously had a peer perform for Qiagen NV.
The last downgrade for Qiagen NV happened on July 14, 2021 when Kepler Cheuvreux changed their price target from N/A to $49.53 for Qiagen NV.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Qiagen, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Qiagen was filed on June 27, 2024 so you should expect the next rating to be made available sometime around June 27, 2025.
While ratings are subjective and will change, the latest Qiagen (QGEN) rating was a upgraded with a price target of $0.00 to $50.00. The current price Qiagen (QGEN) is trading at is $41.03, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.